DiscoverPBS News Hour - SegmentsFDA head explains decision to drop ‘black box’ warnings from menopause hormone treatment
FDA head explains decision to drop ‘black box’ warnings from menopause hormone treatment

FDA head explains decision to drop ‘black box’ warnings from menopause hormone treatment

Update: 2025-11-10
Share

Description

The FDA announced it would begin asking drug companies to remove so-called “black box” warnings for hormones prescribed to treat symptoms of menopause. The FDA says the warning has dissuaded generations of women from taking advantage of the medication that could help them. Ali Rogin discussed more with FDA Commissioner Dr. Marty Makary. PBS News is supported by - https://www.pbs.org/newshour/about/funders. Hosted on Acast. See acast.com/privacy
Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

FDA head explains decision to drop ‘black box’ warnings from menopause hormone treatment

FDA head explains decision to drop ‘black box’ warnings from menopause hormone treatment

PBS News